News & Articles
Rappta Therapeutics Appoints Sunjeet Sawhney as Chief Executive Officer

Rappta Therapeutics Appoints Sunjeet Sawhney as Chief Executive Officer

Rappta Therapeutics announces today the appointment of Sunjeet Sawhney as Chief Executive Officer (CEO) with immediate effect. Rappta’s Co-founder and Founding CEO Mikko Mannerkoski will move to be Chief Financial Officer (CFO) as planned.

Read more
Rappta Therapeutics Raises Series A Financing for the Development of Phosphatase 2A drugs

Rappta Therapeutics Raises Series A Financing for the Development of Phosphatase 2A drugs

Unique phosphatase technology platform offers a new paradigm in oncology. EUR 9M financing, co-led by NVF and Novo Seeds with participation from Advent Life Sciences and a family office, to advance lead compounds to clinical candidate stage.

Read more